Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD 2.560
+0.180 (7.56%)
May 28, 2026, 3:44 PM AEST
Vita Life Sciences Earnings Call Transcripts
Fiscal Year 2026
-
Strong financial results with record revenue and profit, increased dividends, and robust cash reserves were reported. Strategic focus remains on disciplined growth, market expansion, and ESG initiatives, with Malaysia and Vietnam highlighted for standout performance. Regulatory uncertainty in China and competitive pressures were discussed as key risks.
Fiscal Year 2025
-
Record revenue and profit growth were reported, with strong cash reserves and an increased dividend. Strategic expansion in Asia, especially Vietnam, China, and Indonesia, remains a focus, while all AGM resolutions passed with strong support.